Hyperlipidaemia in patients with sleep-related breathing disorders: Prevalence & risk factors

Indian Journal of Medical Research

Volumn 131, Issue 2, 2010, Pages 121-125

  Chou, Yu Ting ^a,c   Chuang, Li Pang ^a,c   Li, Hsueh Yu ^a,b   Fu, Jui Ying ^a,c   Lin, Shih Wei ^a,c   Yang, Cheng Ta ^a   Chen, Ning Hung ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Dyslipidaemias; Obstructive sleep apnoea; Sleep related brathing; Snoring

Indexed keywords

ADULT; AGE DISTRIBUTION; BLOOD ANALYSIS; BODY MASS; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; HYPERURICEMIA; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; POLYSOMNOGRAPHY; PREVALENCE; PROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SLEEP APNEA SYNDROME; SLEEP DISORDERED BREATHING; SNORING; ANOXIA; BREATHING; COMPLICATION; HYPERLIPIDEMIAS; MIDDLE AGED; PROCEDURES; REGRESSION ANALYSIS; SLEEP APNEA, OBSTRUCTIVE;

ADULT; ANOXIA; FEMALE; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; PREVALENCE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RESPIRATION; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; SNORING;

EID: 77649316590     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Bednarek M, Polakowska M, Kurjata P, Kupść W, Plywaczewski R, Zgierska A, et al. Snoring and excessive daytime somnolence and risk of cardiovascular diseases. Pol Arch Med Wewn 2001; 105: 11-7.
2. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle- aged adults. N Engl J Med 1993; 328: 1230-5.
3. Shin C, Joo S, Kim J, Kim T. Prevalence and correlates of habitual snoring in high school students. Chest 2003; 124: 1709-15.
4. Phillips B, Kryger MH. Management of obstructive sleep apnea-hypopnea syndrome: overview. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. 4th ed. Philadelphia: Elsevier Saunders;2005. p.1109-21.
5. Davies RJ, Turner R, Crosby J, Stradling JR. Plasma insulin and lipid levels in untreated obstructive sleep apnoea and snoring; their comparison with matched controls and response to treatment. J Sleep Res 1994; 3: 180-5.
6. Newman AB, Nieto FJ, Guidry U, Lind BK, Redline S, Pickering TG, et al. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 2001; 154: 50-9.
7. Parish JM, Adam T, Facchiano L. Relationship of metabolic syndrome and obstructive sleep apnea. J Clin Sleep Med 2007; 3: 467-72.
8. de la Eva RC, Baur LA, Donaghue KC, Waters KA. Metabolic correlates with obstructive sleep apnea in obese subjects. J Pediatr 2002; 140: 654-9.
9. Kono M, Tatsumi K, Saibara T, Nakamura A, Tanabe N, Takiguchi Y, et al. Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest 2007; 131: 1387-92.
10. Savransky V, Nanayakkara A, Li J, Bevans S, Smith PL, Rodriguez A, et al. Chronic intermittent hypoxia induces atherosclerosis. Am J Respir Crit Care Med 2007; 175: 1290-7.
11. Grunstein RR, Stenlof K, Hedner J, Sjostrom L. Impact of obstructive sleep apnea and sleepiness on metabolic and cardiovascular risk factors in the Swedish Obese Subjects (SOS) Study. Int J Obes Relat Metab Disord 1995; 19: 410-8.
12. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004; 25: 735-41.
13. Grunstein R. Endocrine disorders. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. 4th ed. Philadelphia: Elsevier Saunders; 2005. p. 1237-45.
14. Eisensehr I, Noachtar S. Haematological aspects of obstructive sleep apnoea. Sleep Med Rev 2001; 5: 207-21.
15. Ancoli-Israel S, Klauber MR, Kripke DF, Parker L, Cobarrubias M. Sleep apnea in female patients in a nursing home. Increased risk of mortality. Chest 1989; 96: 1054-8.
16. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999; 22: 667-89.
17. Kiely JL, McNicholas WT. Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome. Eur Respir J 2000; 16: 128-33.
18. Chang HY, Pan WH, Yeh WT, Tsai KS. Hyperuricemia and gout in Taiwan: results from the Nutritional and Health Survey in Taiwan (1993-96). J Rheumatol 2001; 28: 1640-6.
19. Chang HY, Yeh WT, Chang YH, Tsai KS, Pan WH. Prevalence of dyslipidemia and mean blood lipid values in Taiwan: results from the Nutrition and Health Survey in Taiwan (NAHSIT, 1993-1996). Chin J Physiol 2002; 45: 187-97.
20. Tan KC, Chow WS, Lam JC, Lam B, Wong WK, Tam S, et al. HDL dysfunction in obstructive sleep apnea. Atherosclerosis 2006; 184: 377-82.
21. Li J, Thorne LN, Punjabi NM, Sun CK, Schwartz AR, Smith PL, et al. Intermittent hypoxia induces hyperlipidemia in lean mice. Circ Res 2005; 97: 698-706.
22. Li J, Savransky V, Nanayakkara A, Smith PL, O'Donnell CP, Polotsky VY. Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia. J Appl Physiol 2007; 102: 557-63.
23. Wong ND. Metabolic syndrome: cardiovascular risk assessment and management. Am J Cardiovasc Drugs 2007; 7: 259-72.